From Medscape Neurology

Medscape Coverage from the

International Conference on Alzheimer's and Parkinson's Diseases and Related Neurological Disorders (AD/PD) 2017

March 29 - April 02, 2017; Vienna, Austria

March 29 - April 02, 2017 Vienna, Austria

Conference News

Popular News from AD/PD 2015

  • Finally, a Big Win for a Monoclonal in Alzheimer's Finally, a Big Win for a Monoclonal in Alzheimer's Monoclonal antibodies may yet be an answer for treating Alzheimer's disease, results of an early but very encouraging study have shown. Aducanumab lowered amyloid burden and slowed cognitive decline.
  • Green Tea Linked to Lower Risk for Cognitive Decline Green Tea Linked to Lower Risk for Cognitive Decline Frequent consumption of green tea is associated with a dose-dependent lower risk for cognitive decline among Japanese elderly. Black tea and coffee had no effect.
  • New Drug Greatly Reduces Amyloid in CSF, Plasma New Drug Greatly Reduces Amyloid in CSF, Plasma A once-daily, oral secretase inhibitor greatly reduces levels of amyloid in plasma and CSF with a prolonged effect, a study shows. The compound works regardless of APOE epsilon 4 carrier status.

Medscape Neurology©  WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Previous Coverage